glutathione cancer resistance A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung Glutathione-Dependent Pathways in Cancer Cells
Glutathione Dependent Pathways in Cancer Cells glutathione metabolism in cancer progression and treatment resistance responsive nanomedicine leverages tumor redox imbalance for targeted Glutathione S transferases P1 mediated interleukin 6 in tumor associated macrophages augments drug resistance in MCF 7 breast cancer ScienceDirect Glutathione Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor Positive Triple Negative Breast Cancer ACS Nano
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



